SCN8A antisense oligonucleotide (Quiver Bioscience)

N/A

Report date: 2025/06/27 16:57:40
NME

Base Information

Drug NameSCN8A antisense oligonucleotide (Quiver Bioscience)
Drug Alias NameDEE13-SCN8A (ASO)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type VIII alpha subunit modulators
TargetsSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsDevelopmental and epileptic encephalopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuiver Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuiver Bioscience Inc
Inactive CompaniesN/A
Active IndicationsDevelopmental and epileptic encephalopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A